MTMR11

Across TCGA pan-cancer cohorts, MTMR11 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated MTMR11 data layer compared with 19 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher MTMR11 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated MTMR11 expression acts as an unfavorable survival marker, although some lineages such as PDAC and CCRCC show a favorable association.

PDAC, CCRCC, and HNSC are the cancer types where MTMR11 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Median	All	0.458	0.181	.002	59	view →
CCRCC	OS	Tertile	All	0.937	0.714	.005	33	view →
HNSC	DFS	Median	II,III,IV	0.870	0.253	.031	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

MTMR11–PDAC (DFS)

Open the PDAC breakdown →